2 hours ago • stocktitan.net
Vor Bio Initiates First Patient in Worldwide Phase 3 UPSTREAM SjD Trial Evaluating Telitacicept for Primary Sjögren’s Disease
2 hours ago • stocktitan.net
Vor Bio Initiates First Patient in Worldwide Phase 3 UPSTREAM SjD Trial Evaluating Telitacicept for Primary Sjögren’s Disease2 hours ago • stocktitan.net
IDEAYA Biosciences Initiates Phase 1 Trial Combining IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, Across DLL3-High Solid Tumors2 hours ago • streetinsider.com
IDEAYA Biosciences Initiates Phase 1 Trial Combining IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, for DLL3 High Solid Tumors Like5 hours ago • femtechinsider.com
Madorra Begins Initial Patient Enrollment in Key Trial of Non-Hormonal Vulvovaginal Atrophy Therapy5 hours ago • clinicaltrialvanguard.com
Patient One Receives Initial Treatment in RAD 402 Prostate Cancer Study2026-03-30 • southfloridahospitalnews.com
Sarasota Memorial Begins Initial Patient Enrollment in New Cancer Trial2026-03-30 • PR Newswire
IDEAYA Biosciences Initiates Phase 1 Trial Combining IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, for DLL3-High Solid Tumors2026-03-28 • manilatimes.net
Radiopharm Theranostics Administers Initial Patient for Phase 1 Clinical Trial of RAD 402 for Advanced Prostate Cancer2026-03-27 • bitget.com
C4 Therapeutics Reports Initial Patient Treated in Phase 1b Trial Using Cemsidomide and Elranatamab (ELREXFIO) for Relapsed/Refractory Multiple Myel2026-03-27 • dicardiology.com
iPerf registers initial patient for clinical trial of dualflow femoral arterial cannula2026-03-26 • businesswire.com
Canadian Study Begins with First Patient Receiving Innovative Drug Candidate for Brain Injury Prevention in Dialysis Patients2026-03-26 • natlawreview.com
WAVES Study Begins with Initial Patient Enrollment for Moderate to Severe Vulvovaginal Atrophy Treatment2026-03-26 • globenewswire.com
C4 Therapeutics Reports Initial Patient Treated in Phase 1b Trial Using Cemsidomide and Elranatamab (ELREXFIO®) for Advanced Multiple Myeloma2026-03-25 • PR Newswire
Iterion Therapeutics is broadening its clinical development of Tegavivint, a novel Wnt/β-Catenin inhibitor, for colorectal cancer after the first patient received the treatment.2026-03-25 • menafn.com
iPerf initiates its first patient in a clinical trial assessing a novel dual-flow femoral arterial cannula designed to provide cardiopulmonary support2026-03-25 • biz.chosun.com
IntoCell finishes initial patient treatment in phase 1 antibody drug conjugate trial in South Korea2026-03-25 • pharmadispatch.com
Australian trial begins with first patient treated to address ALS’s fundamental cause2026-03-25 • globenewswire.com
Avalyn Reports Initial Patient Administered in AURA Phase 2 Trial Assessing AP02 and Inhaled Nintedanib for Idiopathic Pulmonary Fibrosis2026-03-25 • PR Newswire
Complement Therapeutics Reports Initial Patient Treated with CTx001 in the Opti-GAIN Study Evaluating Geographic Atrophy Due to Age-Related Macular Degeneration2026-03-25 • PR Newswire
Hope Medicine Reports Initial Patient Received Treatment in Phase III Endometriosis Trial2026-03-24 • EIN Presswire
WAVES Study Begins with Initial Patient Enrollment for Moderate to Severe Vulvovaginal Atrophy Treatment2026-03-24 • PR Newswire
Alphamab Oncology Reports Initial Patient Treated in Phase III Trial Evaluating Anbenitamab (KN026) Alongside HB1801 and Chemotherapy for Breast Cancer Adjuvant Therapy2026-03-24 • prnewswire.co.uk
Celosia Therapeutics Reports Initial Patient Treated in Phase 1b Clinical Trial of CTx1000 for Amyotrophic Lateral Sclerosis2026-03-18 • PR Newswire
Biotheryx Reports Initial Patient Administered in BTX-9341-101s Dose Expansion Phase Targeting HR+/HER2- Breast Cancer2026-03-18 • PR Newswire
Kali Therapeutics Reports Initial Patient Treated in Phase 1a Clinical Trial of KT501 in Rheumatoid Arthritis2026-03-17 • businesswire.com
Eccogene Reports Initial Patient Enrollment in the MIST Phase 2a Trial Assessing ECC4703 Alongside Semaglutide for Obesity Treatment2026-03-17 • clinicaltrialvanguard.com
Bioversys Administers Initial Treatment to Participant in ALPE TB Trial Phase 2b2026-03-17 • PR Newswire
Alphamab Oncology Reports Initial Patient Treated in Phase I Clinical Trial of Bispecific Antibody JSKN0272026-03-14 • citybiz.co
Bloom Science in San Diego Administers Initial Treatment for Obesity Patients — Diet Not Needed2026-03-14 • pharmatimes.com
APAC trial begins with Aplagon for first patient in phase 2a27 minutes ago • prnewswire.co.uk
The Autoinjector Market is Projected to Reach $300.46 Billion by 2031 | MarketsandMarkets™1 hour ago • cbn.com.cy
Manufacturing output rose 3.7 percent year over year during January1 hour ago • venezuelanalysis.com
The Trump Administration granted new licenses allowing Western companies to mine in Venezuela.1 hour ago • sourcingjournal.com
Textile Exchange Introduces Initial Life Cycle Assessments Emphasizing Key Cotton Data Deficiencies1 hour ago • kxii.com
Stephen Durant authorizes significant wastewater improvements to accommodate expansion1 hour ago • blogs.worldbank.org
Agriculture Can Drive Papua New Guinea’s Economic Growth1 hour ago • streetwisereports.com
Innovative Firm Discovers New Arthritis Remedy for Dogs1 hour ago • scanx.trade
Caprolactam Chemical Limited Receives Complete Agreement on Postal Ballot Proposals1 hour ago • nzherald.co.nz
Auckland travel show forecasts strong interest from New Zealanders opting for vacations instead of home improvements1 hour ago • airandspaceforces.com
Construction starts on a test silo for the Sentinel ICBM.1 hour ago • gmk.center
Iran’s steel output is declining because of the Middle East conflict1 hour ago • tbsnews.net
Bangladesh’s Islamic finance transitioned from early mixed models to a period of significant regulatory change12 minutes ago • EIN Presswire
St. George Woman Awarded Judgment in Civil Rights Case Following Wrongful Arrest Allegations12 minutes ago • EIN Presswire
Planet Welcomes Michael Thayer to Tennessee Office12 minutes ago • EIN Presswire
Richard Jaffe Discusses Leadership, Culture, and Long-Term Law Firm Growth on The Firm Report2026-03-30 • thedefensepost.com
Russian Authorities Report Single Death Following Drone Attack in Rostov Region2026-03-30 • thedefensepost.com
Russia Announces Fire Following Attack on Significant Baltic Port9 hours ago • therecord.media
Russian court convicts prominent card fraud leader ‘Flint’ and 25 accomplices1 hour ago • scanx.trade
Caprolactam Chemical Limited Receives Complete Agreement on Postal Ballot Proposals1 hour ago • scanx.trade
Jigar Cables Begins Selling Wires and Cables from Its Newly Built Factory1 hour ago • indianexpress.com
Haryana suggests a potential increase of as much as 75 percent in collector rates for residential agricultural and commercial properties.1 hour ago • fuelcellsworks.com
Lincoln State University Launches Advanced Hydrogen Laboratory Featuring Innovative Metal‑hydride Testing Equipment1 hour ago • h2-view.com
CPH2 anticipates its initial income from commercial electrolysers without membranes occurring in 20241 hour ago • in.investing.com
Hydrogen Capital Growth will cease trading on the London Stock ExchangeStay ahead with real-time headlines from top sources, categorized by sector and country.